University College London Hospitals NHS Foundation Trust was seeking the court's authority to administer a treatment known as PRN100 to a patient who was suffering from sporadic CJD. Permission was granted.
The P was suffering from sporadic CJD (a life threatening condition where the P may survive only 6 months) and he and his family wanted to him to undergo treatment with PRN100, a novel and experimental treatment. The court had to weigh up the risks and benefits of such treatment.
The court agreed that the P could undergo the treatment as it was plainly in his best interests.
Read the full text of the judgment on Bailii
Case summaries on every Court of Protection case & other relevant decisions with links to the full judgment where available.
Free email alert
Get the latest cases & news delivered to your inbox with our free email updates.
Useful books from Bath Publishing